137 related articles for article (PubMed ID: 26998278)
21. Deficiency of the DNA repair protein nibrin increases the basal but not the radiation induced mutation frequency in vivo.
Wessendorf P; Vijg J; Nussenzweig A; Digweed M
Mutat Res; 2014 Nov; 769():11-6. PubMed ID: 25771721
[TBL] [Abstract][Full Text] [Related]
22. NBN and XRCC3 genetic variants in childhood acute lymphoblastic leukaemia.
Smolkova B; Dusinska M; Hemminki K
Cancer Epidemiol; 2014 Oct; 38(5):563-8. PubMed ID: 25176580
[TBL] [Abstract][Full Text] [Related]
23. Association of the MTHFR Gene C677T Polymorphism with Breast Cancer in a Turkish Population.
Kaya EF; Karakus N; Ulusoy AN; Özaslan C; Kara N
Oncol Res Treat; 2016; 39(9):534-8. PubMed ID: 27614738
[TBL] [Abstract][Full Text] [Related]
24. Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.
Loke J; Pearlman A; Upadhyay K; Tesfa L; Shao Y; Ostrer H
Hum Mol Genet; 2015 Jun; 24(11):3030-7. PubMed ID: 25652403
[TBL] [Abstract][Full Text] [Related]
25. Murine double minute clone 2,309T/G and 285G/C promoter single nucleotide polymorphism as a risk factor for breast cancer: a Polish experience.
Piotrowski P; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
Int J Biol Markers; 2012 Jul; 27(2):e105-10. PubMed ID: 22467100
[TBL] [Abstract][Full Text] [Related]
26. Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters.
Naidu R; Har YC; Taib NA
Scand J Clin Lab Invest; 2011 Oct; 71(6):500-6. PubMed ID: 21745146
[TBL] [Abstract][Full Text] [Related]
27. Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide.
Eich M; Roos WP; Dianov GL; Digweed M; Kaina B
Mol Pharmacol; 2010 Nov; 78(5):943-51. PubMed ID: 20729302
[TBL] [Abstract][Full Text] [Related]
28. Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.
Pooja S; Chaudhary P; Nayak LV; Rajender S; Saini KS; Deol D; Kumar S; Bid HK; Konwar R
Cytokine; 2012 Oct; 60(1):122-8. PubMed ID: 22818022
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
[TBL] [Abstract][Full Text] [Related]
30. Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome.
Lins S; Kim R; Krüger L; Chrzanowska KH; Seemanova E; Digweed M
Gene; 2009 Nov; 447(1):12-7. PubMed ID: 19635536
[TBL] [Abstract][Full Text] [Related]
31. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
32. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
33. NBN 657del5 heterozygous mutations and colorectal cancer risk in the Czech Republic.
Pardini B; Naccarati A; Polakova V; Smerhovsky Z; Hlavata I; Soucek P; Novotny J; Vodickova L; Tomanova V; Landi S; Vodicka P
Mutat Res; 2009 Jun; 666(1-2):64-7. PubMed ID: 19393249
[TBL] [Abstract][Full Text] [Related]
34. RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women.
Smolarz B; Zadrożny M; Duda-Szymańska J; Makowska M; Samulak D; Michalska MM; Mojs E; Bryś M; Forma E; Romanowicz-Makowska H
Pol J Pathol; 2013 Apr; 64(1):39-43. PubMed ID: 23625599
[TBL] [Abstract][Full Text] [Related]
35. Genetic Association between ERCC2, NBN, RAD51 Gene Variants and Osteosarcoma Risk: a Systematic Review and Meta-Analysis.
Mehdinejad M; Sobhan MR; Mazaheri M; Zare Shehneh M; Neamatzadeh H; Kalantar SM
Asian Pac J Cancer Prev; 2017 May; 18(5):1315-1321. PubMed ID: 28610420
[TBL] [Abstract][Full Text] [Related]
36. DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil.
Dufloth RM; Costa S; Schmitt F; Zeferino LC
Genet Mol Res; 2005 Dec; 4(4):771-82. PubMed ID: 16475125
[TBL] [Abstract][Full Text] [Related]
37. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
38. Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk.
Su CH; Chang WS; Hu PS; Hsiao CL; Ji HX; Liao CH; Yueh TC; Chuang CL; Tsai CW; Hsu CM; Lane HY; Bau DT
Cancer Genomics Proteomics; 2015; 12(6):359-67. PubMed ID: 26543082
[TBL] [Abstract][Full Text] [Related]
39. Nijmegen breakage syndrome: the clearance pathway for mutant nibrin protein is allele specific.
Salewsky B; Wessendorf P; Hirsch D; Krenzlin H; Digweed M
Gene; 2013 May; 519(2):217-21. PubMed ID: 23458873
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor alpha and beta and interferon gamma gene polymorphisms in Turkish breast cancer patients.
Karakus N; Kara N; Ulusoy AN; Ozaslan C; Bek Y
DNA Cell Biol; 2011 Jun; 30(6):371-7. PubMed ID: 21323572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]